FY 2012 Request for National Institute of Biomedical Imaging and Bioengineering

Share This

Share/Save
Publication date: 
25 February 2011
Number: 
25

“The  mission of the National Institute of Biomedical Imaging and Bioengineering  (NIBIB) is to improve health by leading the development and accelerating the  application of biomedical technologies. The Institute is committed to  integrating the physical and engineering sciences with the life sciences to  advance basic research and medical care.” ~NIBIB’s mission overview

The  budget for NIBIB would increase by 1.8 percent or $5.7 million from $316.4  million to $322.1 million under the FY 2012 budget request submitted by  President Obama to Congress. NIBIB is a part of the National Institutes of  Health, for which the Administration requested a $745 million increase to $32  billion.

Please  note that all comparisons given are based on the FY 2010 enacted levels because  no full-year FY 2011 appropriations bills have been passed by Congress.

NIBIB’s  budget document explains the changes requested as follows:

"Research  Project Grants (RPGs; -$1.096 million; total $231.454 million):

"NIBIB  will continue to fund a substantial number of RPGs, 545 awards in FY 2012 (a  decrease of 44 from FY 2010).”

"Training  (+$0.442 million; total $11.510 million):

“NIH  will provide an across-the-board increase in FY 2012 of four percent for  stipends levels under the Ruth L. Kirschstein National Research Service Award  training program to continue efforts to attain the stipend levels recommended  by the National Academy of Sciences. This will build on the two percent  increase in stipend levels for FY 2011. Stipend levels were nearly flat for  several years and the requested increase will help to sustain the development  of a highly qualified biomedical research workforce. Training costs are also  reflected in the FY 2012 Technological Competitiveness - Bridging the Sciences  program total, as all NIBIB training activities are within that program.”

"Research  & Development Contracts (+$4.669 million; total $17.706 million):

“NIBIB’s  R&D contracts total includes NIBIB’s share of several trans-NIH  initiatives, such as the Therapies for Rare and Neglected Diseases program, the  Basic Behavioral and Social Sciences Opportunity Network (OppNet), and support  for a new synchrotron at the Brookhaven National Laboratory.”